Provided that CD44 is a bona fide GCSC marker [4] and that FGFR2 is the most commonly deregulated RTK pathway in GC, CD44+/FGFR+ GC cells could be a key subset dictating tumor initiation, suggesting some coordination between these two molecules. This evidence concerns the gene CD44 and neoplasm.